Introductory Note: This Amendment No. 2 to the statement on Schedule 13G is filed on behalf of
the Reporting Persons, in respect of shares of Common Stock, par value $0.0001 per share (Common
Stock), of Hansen Medical, Inc. (the Issuer).
Item 1(a). Name of Issuer:
Hansen Medical, Inc.
Item 1(b). Address of Issuers Principal Executive Officers:
380 North Bernardo Avenue
Mountain View, California 94043
Item 2(a). Name of Person(s) Filing
:
Prospect Venture Partners II, L.P. (PVP II)
Prospect Associates II, L.P. (PA II)
Prospect Management Co. II, L.L.C. (PMC II)
Item 2(b). Address of Principal Business Office:
Prospect Venture Partners
435 Tasso Street, Suite 200
Palo Alto, California 94301
Item 2(c). Citizenship:
PVP II is a Delaware limited partnership.
PA II is a Delaware limited partnership.
PMC II is a Delaware limited liability company.
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.0001 per share.
Item 2(e). CUSIP Number:
411307 10 1
|
|
|
Item 3.
|
|
If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether
the Person Filing is a:
|
Not applicable.
Page 5